Lenacapavir HIV prevention faces SA supply constraints

Original Article by Tamar Kahn | Business Day | 1 September 2026

Lenacapavir HIV prevention could accelerate South Africa’s epidemic control, but severe supply constraints are limiting the rollout.

AI Image | Chat-GPT

Lenacapavir HIV prevention could accelerate South Africa’s epidemic control, but severe supply constraints are limiting the rollout.

Subscription Required

You must be a subscriber to access all of this content.

Already a subscriber? Log in here

New research on statins and dementia links earlier treatment to a 15% lower dementia risk in people with type 2 diabetes.

Young adult mental health claims have risen 80% in a decade, Discovery Health data shows, as earlier care-seeking reshapes demand.

The Dis-Chem succession is pivotal as founder Ivan Saltzman resigns from formal roles. Learn about the changes happening now.